LEUKEMIA & LYMPHOMA SOCIETY

View full entity profile (contributions, contracts, SEC) →

Lobbying Spend

—

Filings

Firms Hired

Active Period

2000–2015

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2015	—	4	1
2014	—	4	1
2013	—	4	1
2012	—	5	2
2011	—	4	1
2010	—	4	1
2009	—	4	1
2008	—	4	1
2007	—	4	2
2006	—	2	1
2005	—	1	1
2004	—	1	1
2003	—	1	1
2002	—	2	1
2001	—	2	1
2000	—	4	1

Hired Firms

Lobbying firms retained by this client; amounts are client-reported expenses when available

Firm Name	Reported Spend	Filings
Polsinelli PC	—	14
ROPES & GRAY, LLP	—	8
TURNER & GOSS LLP	—	22
BENNETT TURNER & COLEMAN LLP	—	6

Government Bodies Lobbied

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
HOUSE OF REPRESENTATIVES	44
SENATE	44
Executive Office of the President (EOP)	6
Health & Human Services, Dept of (HHS)	1

Top Issues

Most frequently reported lobbying issues

Issue Code	Description	Reports
Budget/Appropriations	Budget/Appropriations	34
Health Issues	Health Issues	26
Medical/Disease Research/Clinical Labs	Medical/Disease Research/Clinical Labs	15
Medicare/Medicaid	Medicare/Medicaid	13

Bills Explicitly Cited (25)

Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded

H.R. 1600114th Congress

Patients' Access to Treatments Act of 2015

2015 · fourth_quarter · Firm: Polsinelli PC

Open original LDA filing ↗

Cited source text and reported amounts

Issues pertaining to quality of care for blood cancers [Patients Access to Treatment Act (H.R. 1600) - all provisions; 21st Century Cures Act (H.R. 6); Cancer Drug Coverage Parity Act of 2015 (H.R. 2739); Cancer Drug Coverage Parity Act of 2015 (S. 1566)]

Client expense: — · Firm income: $50,000

Matched citations: H.R. 1600

H.R. 2624114th Congress

Part D Beneficiary Appeals Fairness Act

2015 · fourth_quarter · Firm: Polsinelli PC

Open original LDA filing ↗

Cited source text and reported amounts

Issues pertaining to the coverage of cancer therapies [Part D Beneficiary Appeals Fairness Act (H.R. 2624); Part D Beneficiary Appeals Fairness Act (S. 1488)]

Client expense: — · Firm income: $50,000

Matched citations: H.R. 2624

H.R. 2739114th Congress

Cancer Drug Coverage Parity Act of 2015

2015 · fourth_quarter · Firm: Polsinelli PC

Open original LDA filing ↗

Cited source text and reported amounts

Issues pertaining to quality of care for blood cancers [Patients Access to Treatment Act (H.R. 1600) - all provisions; 21st Century Cures Act (H.R. 6); Cancer Drug Coverage Parity Act of 2015 (H.R. 2739); Cancer Drug Coverage Parity Act of 2015 (S. 1566)]

Client expense: — · Firm income: $50,000

Matched citations: H.R. 2739

H.R. 6114th Congress

21st Century Cures Act

2015 · fourth_quarter · Firm: Polsinelli PC

Open original LDA filing ↗

Cited source text and reported amounts

Issues pertaining to quality of care for blood cancers [Patients Access to Treatment Act (H.R. 1600) - all provisions; 21st Century Cures Act (H.R. 6); Cancer Drug Coverage Parity Act of 2015 (H.R. 2739); Cancer Drug Coverage Parity Act of 2015 (S. 1566)]

Client expense: — · Firm income: $50,000

Matched citations: H.R. 6

Show 21 more cited filings

S. 1488114th Congress

Part D Beneficiary Appeals Fairness Act

2015 · fourth_quarter · Firm: Polsinelli PC

Open original LDA filing ↗

Cited source text and reported amounts

Issues pertaining to the coverage of cancer therapies [Part D Beneficiary Appeals Fairness Act (H.R. 2624); Part D Beneficiary Appeals Fairness Act (S. 1488)]

Client expense: — · Firm income: $50,000

Matched citations: S. 1488

S. 1566114th Congress

Cancer Drug Coverage Parity Act of 2015

2015 · fourth_quarter · Firm: Polsinelli PC

Open original LDA filing ↗

Cited source text and reported amounts

Issues pertaining to quality of care for blood cancers [Patients Access to Treatment Act (H.R. 1600) - all provisions; 21st Century Cures Act (H.R. 6); Cancer Drug Coverage Parity Act of 2015 (H.R. 2739); Cancer Drug Coverage Parity Act of 2015 (S. 1566)]

Client expense: — · Firm income: $50,000

Matched citations: S. 1566

H.R. 1600114th Congress

Patients' Access to Treatments Act of 2015

2015 · third_quarter · Firm: Polsinelli PC

Open original LDA filing ↗

Cited source text and reported amounts

Issues pertaining to quality of care for blood cancers [Patients Access to Treatment Act (H.R. 1600) - all provisions; 21st Century Cures Act (H.R. 6); Cancer Drug Coverage Parity Act of 2015 (H.R. 2739); Cancer Drug Coverage Parity Act of 2015 (S. 1566)]

Client expense: — · Firm income: $50,000

Matched citations: H.R. 1600

H.R. 2624114th Congress

Part D Beneficiary Appeals Fairness Act

2015 · third_quarter · Firm: Polsinelli PC

Open original LDA filing ↗

Cited source text and reported amounts

Issues pertaining to the coverage of cancer therapies [Part D Beneficiary Appeals Fairness Act (H.R. 2624); Part D Beneficiary Appeals Fairness Act (S. 1488)]

Client expense: — · Firm income: $50,000

Matched citations: H.R. 2624

H.R. 2739114th Congress

Cancer Drug Coverage Parity Act of 2015

2015 · third_quarter · Firm: Polsinelli PC

Open original LDA filing ↗

Cited source text and reported amounts

Issues pertaining to quality of care for blood cancers [Patients Access to Treatment Act (H.R. 1600) - all provisions; 21st Century Cures Act (H.R. 6); Cancer Drug Coverage Parity Act of 2015 (H.R. 2739); Cancer Drug Coverage Parity Act of 2015 (S. 1566)]

Client expense: — · Firm income: $50,000

Matched citations: H.R. 2739

H.R. 6114th Congress

21st Century Cures Act

2015 · third_quarter · Firm: Polsinelli PC

Open original LDA filing ↗

Cited source text and reported amounts

Issues pertaining to quality of care for blood cancers [Patients Access to Treatment Act (H.R. 1600) - all provisions; 21st Century Cures Act (H.R. 6); Cancer Drug Coverage Parity Act of 2015 (H.R. 2739); Cancer Drug Coverage Parity Act of 2015 (S. 1566)]

Client expense: — · Firm income: $50,000

Matched citations: H.R. 6

S. 1488114th Congress

Part D Beneficiary Appeals Fairness Act

2015 · third_quarter · Firm: Polsinelli PC

Open original LDA filing ↗

Cited source text and reported amounts

Issues pertaining to the coverage of cancer therapies [Part D Beneficiary Appeals Fairness Act (H.R. 2624); Part D Beneficiary Appeals Fairness Act (S. 1488)]

Client expense: — · Firm income: $50,000

Matched citations: S. 1488

S. 1566114th Congress

Cancer Drug Coverage Parity Act of 2015

2015 · third_quarter · Firm: Polsinelli PC

Open original LDA filing ↗

Cited source text and reported amounts

Issues pertaining to quality of care for blood cancers [Patients Access to Treatment Act (H.R. 1600) - all provisions; 21st Century Cures Act (H.R. 6); Cancer Drug Coverage Parity Act of 2015 (H.R. 2739); Cancer Drug Coverage Parity Act of 2015 (S. 1566)]

Client expense: — · Firm income: $50,000

Matched citations: S. 1566

H.R. 1600114th Congress

Patients' Access to Treatments Act of 2015

2015 · second_quarter · Firm: Polsinelli PC

Open original LDA filing ↗

Cited source text and reported amounts

Issues pertaining to quality of care for blood cancers [Patients Access to Treatment Act (H.R. 1600) - all provisions; 21st Century Cures Act (H.R. 6)]

Client expense: — · Firm income: $50,000

Matched citations: H.R. 1600

H.R. 2624114th Congress

Part D Beneficiary Appeals Fairness Act

2015 · second_quarter · Firm: Polsinelli PC

Open original LDA filing ↗

Cited source text and reported amounts

Issues pertaining to the coverage of cancer therapies [Part D Beneficiary Appeals Fairness Act (H.R. 2624)]

Client expense: — · Firm income: $50,000

Matched citations: H.R. 2624

H.R. 6114th Congress

21st Century Cures Act

2015 · second_quarter · Firm: Polsinelli PC

Open original LDA filing ↗

Cited source text and reported amounts

Issues pertaining to quality of care for blood cancers [Patients Access to Treatment Act (H.R. 1600) - all provisions; 21st Century Cures Act (H.R. 6)]

Client expense: — · Firm income: $50,000

Matched citations: H.R. 6

H.R. 1660114th Congress

Federal Savings Association Charter Flexibility Act of 2015

2015 · first_quarter · Firm: Polsinelli PC

Open original LDA filing ↗

Cited source text and reported amounts

Issues pertaining to quality of care for blood cancers [Patients Access to Treatment Act, H.R. 1660 - all provisions; 21st Century Cures Act]

Client expense: — · Firm income: $50,000

Matched citations: H.R. 1660

H.R. 1801113th Congress

Cancer Drug Coverage Parity Act of 2013

2014 · fourth_quarter · Firm: Polsinelli PC

Open original LDA filing ↗

Cited source text and reported amounts

Issues pertaining to quality of care for blood cancers [Patients Access to Treatment Act, H.R. 460 - all provisions; Cancer Drug Coverage Parity Act, H.R. 1801 - all provisions; Kids First Research Act, H.R. 2019 - all provisions; Medicare exceptions process within prescription drug plans, H.R. 2827 - all provisions]

Client expense: — · Firm income: $50,000

Matched citations: H.R. 1801

H.R. 2019113th Congress

Gabriella Miller Kids First Research Act

2014 · fourth_quarter · Firm: Polsinelli PC

Open original LDA filing ↗

Cited source text and reported amounts

Issues pertaining to quality of care for blood cancers [Patients Access to Treatment Act, H.R. 460 - all provisions; Cancer Drug Coverage Parity Act, H.R. 1801 - all provisions; Kids First Research Act, H.R. 2019 - all provisions; Medicare exceptions process within prescription drug plans, H.R. 2827 - all provisions]

Client expense: — · Firm income: $50,000

Matched citations: H.R. 2019

H.R. 2827113th Congress

Part D Beneficiary Appeals Fairness Act

2014 · fourth_quarter · Firm: Polsinelli PC

Open original LDA filing ↗

Cited source text and reported amounts

Issues pertaining to quality of care for blood cancers [Patients Access to Treatment Act, H.R. 460 - all provisions; Cancer Drug Coverage Parity Act, H.R. 1801 - all provisions; Kids First Research Act, H.R. 2019 - all provisions; Medicare exceptions process within prescription drug plans, H.R. 2827 - all provisions]

Client expense: — · Firm income: $50,000

Matched citations: H.R. 2827

H.R. 460113th Congress

Patients' Access to Treatments Act of 2013

2014 · fourth_quarter · Firm: Polsinelli PC

Open original LDA filing ↗

Cited source text and reported amounts

Issues pertaining to quality of care for blood cancers [Patients Access to Treatment Act, H.R. 460 - all provisions; Cancer Drug Coverage Parity Act, H.R. 1801 - all provisions; Kids First Research Act, H.R. 2019 - all provisions; Medicare exceptions process within prescription drug plans, H.R. 2827 - all provisions]

Client expense: — · Firm income: $50,000

Matched citations: H.R. 460

H.R. 1801113th Congress

Cancer Drug Coverage Parity Act of 2013

2014 · third_quarter · Firm: Polsinelli PC

Open original LDA filing ↗

Cited source text and reported amounts

Issues pertaining to quality of care for blood cancers [Patients Access to Treatment Act, H.R. 460 - all provisions; Cancer Drug Coverage Parity Act, H.R. 1801 - all provisions; Kids First Research Act, H.R. 2019 - all provisions; Medicare exceptions process within prescription drug plans, H.R. 2827 - all provisions]

Client expense: — · Firm income: $50,000

Matched citations: H.R. 1801

H.R. 2019113th Congress

Gabriella Miller Kids First Research Act

2014 · third_quarter · Firm: Polsinelli PC

Open original LDA filing ↗

Cited source text and reported amounts

Issues pertaining to quality of care for blood cancers [Patients Access to Treatment Act, H.R. 460 - all provisions; Cancer Drug Coverage Parity Act, H.R. 1801 - all provisions; Kids First Research Act, H.R. 2019 - all provisions; Medicare exceptions process within prescription drug plans, H.R. 2827 - all provisions]

Client expense: — · Firm income: $50,000

Matched citations: H.R. 2019

H.R. 2827113th Congress

Part D Beneficiary Appeals Fairness Act

2014 · third_quarter · Firm: Polsinelli PC

Open original LDA filing ↗

Cited source text and reported amounts

Issues pertaining to quality of care for blood cancers [Patients Access to Treatment Act, H.R. 460 - all provisions; Cancer Drug Coverage Parity Act, H.R. 1801 - all provisions; Kids First Research Act, H.R. 2019 - all provisions; Medicare exceptions process within prescription drug plans, H.R. 2827 - all provisions]

Client expense: — · Firm income: $50,000

Matched citations: H.R. 2827

H.R. 460113th Congress

Patients' Access to Treatments Act of 2013

2014 · third_quarter · Firm: Polsinelli PC

Open original LDA filing ↗

Cited source text and reported amounts

Issues pertaining to quality of care for blood cancers [Patients Access to Treatment Act, H.R. 460 - all provisions; Cancer Drug Coverage Parity Act, H.R. 1801 - all provisions; Kids First Research Act, H.R. 2019 - all provisions; Medicare exceptions process within prescription drug plans, H.R. 2827 - all provisions]

Client expense: — · Firm income: $50,000

Matched citations: H.R. 460

H.R. 1801113th Congress

Cancer Drug Coverage Parity Act of 2013

2014 · second_quarter · Firm: Polsinelli PC

Open original LDA filing ↗

Cited source text and reported amounts

Issues pertaining to quality of care for blood cancers [Patients Access to Treatment Act, H.R. 460 - all provisions; Cancer Drug Coverage Parity Act, H.R. 1801 - all provisions; Kids First Research Act, H.R. 2019 - all provisions; Medicare exceptions process within prescription drug plans, H.R. 2827 - all provisions]

Client expense: — · Firm income: $50,000

Matched citations: H.R. 1801

Source: Senate LDA

LEUKEMIA & LYMPHOMA SOCIETY — Lobbying Disclosure | Poliscope